Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02639039Phase 4Completed
Phase 4, randomised, single-blind trial (2 arms), sponsored by Baylor Scott & White Health. Primary endpoints: Numerical Pain Rating Score at 6 weeks and Patient Specific Functional Scale at 6 weeks. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02639039.